Cognition and Ultrasound
Part of paid clinical trials in Minneapolis, Minnesota.
- Sponsor
- University of Minnesota
- Study ID
- NCT07220655
- Status
- Recruiting
Conditions
- Healthy Participants
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Low-Intensity Focused Ultrasound (FUS or LIFU) — DEVICEWe will use an established, currently-marketed device to deliver LIFU neuromodulation.
Study Details
Our primary goal is to investigate the role of Low-Intensity Focused Ultrasound (LIFU) neuromodulation on deep brain targets, and its potential to improve cognition
Key Dates
- Start date
- Jun 1, 2024
- Status verified
- Oct 2025
- Primary completion
- Jul 1, 2028
- Completion
- Jul 1, 2028
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: Low-Intensity Focused Ultrasound
Primary Outcome Measure
Deep Brain Targets Reached [ Time Frame: Hour 1 ]
Central Contacts
- Miriam Freedmantel:612-625-3330
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Minnesota | Minneapolis | Minnesota | 55455 |
Find similar trials in Minneapolis, MN
By research site
Related Studies
- Cognitive Strategies in Early Psychosis 1PHASE3 · Recruiting · University of Minnesota · Minneapolis, Minnesota
- Evaluate the Effect of Vimseltinib on Pharmacokinetics of Combined Oral Contraceptive (Ethinyl Estradiol/Levonorgestrel)PHASE1 · Recruiting · Deciphera Pharmaceuticals, LLC · Saint Paul, Minnesota
- A Study to Evaluate Dermal Open-Flow Microperfusion and Plasma Pharmacokinetic Study of Multiple Doses of Oral Povorcitinib or Topical Ruxolitinib Cream in Healthy Adult ParticipantsPHASE1 · Recruiting · Incyte Corporation · Dilworth, Minnesota
- A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)PHASE1 · Recruiting · Equilibra Bioscience LLC · Glendale, California